Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nicotinamide 250mg tablets
0906022K0AAAPAP
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | 1,067 |
|
Nicotinamide 500mg capsules
0906022K0AAAGAG
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | 524 |
|
Nicotinamide 500mg tablets
0906022K0AAACAC
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | 100 |
|
Nicotinamide 50mg tablets
0906022K0AAAAAA
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | 21 |
|
Nicotinamide 100mg capsules
0906022K0AAARAR
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | 2 |
|
Nicotinamide 100mg tablets
0906022K0AAABAB
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | No data available |
|
Nicotinamide 250mg capsules
0906022K0AAASAS
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | No data available |
|
Nicotinamide 250mg modified-release tablets
0906022K0AAAQAQ
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | No data available |
|
Nicotinamide 25mg/5ml oral solution
0906022K0AAAKAK
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | No data available |
|
Nicotinamide 500mg/5ml oral solution
0906022K0AAAJAJ
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | No data available |
|
Nicotinamide 50mg capsules
0906022K0AAATAT
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | No data available |
|
Nicotinamide 750mg capsules
0906022K0AAAUAU
|
Nicotinamide (Systemic) | Nicotinamide | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.